Lapatinib Terminated Phase 1 Trials for Estrogen Receptor Positive / Stage IV Breast Cancer / Estrogen Receptor Negative / HER2/Neu Positive / Recurrent Breast Carcinoma / Progesterone Receptor Positive / Progesterone Receptor Negative Treatment